CRISPR Therapeutics (CRSP) Stock
CRISPR Therapeutics (CRSP) closed at $42.24 on Nov 13, 2026; its Tenet Score is 54 of 100 against 409 Healthcare peers.
30 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $42.24
- Nov 13, 2026
- Market cap
- $4.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 41.75 – 63.45
- low → high
- Tenet Score
- 54/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
CRISPR Therapeutics AG scores 54/100. Mixed. Strongest on financial health and value, quality is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Definium Therapeutics Inc.DFTX | 50 | $4.4B |
| Relay Therapeutics IncRLAY | 43 | $4.0B |
| Xenon Pharmaceuticals IncXENE | 45 | $4.0B |
| Tarsus Pharmaceuticals IncTARS | 33 | $4.0B |
| Amylyx Pharmaceuticals IncAMLX | 57 | $3.9B |
| Viking Therapeutics IncVKTX | 35 | $3.7B |
| Organon & Co.OGN | 45 | $3.7B |
| Enliven Therapeutics IncELVN | 63 | $3.6B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.6B |
| Arcutis Biotherapeutics IncARQT | 41 | $3.6B |
Compare CRISPR Therapeutics with
Common questions
What sector and industry is CRISPR Therapeutics in?
CRISPR Therapeutics is in the Healthcare sector and the Drugs industry.
What is CRISPR Therapeutics' Tenet Score?
CRISPR Therapeutics' Tenet Score is 54 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




